BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi M, Zhang J, Wang Y, Han Y, Zhao X, Hu H, Qiao M, Chen D. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy. Acta Biomater 2022:S1742-7061(22)00415-9. [PMID: 35843594 DOI: 10.1016/j.actbio.2022.07.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Song J, Cheng M, Xie Y, Li K, Zang X. Efficient tumor synergistic chemoimmunotherapy by self-augmented ROS-responsive immunomodulatory polymeric nanodrug. J Nanobiotechnology 2023;21:93. [PMID: 36927803 DOI: 10.1186/s12951-023-01842-1] [Reference Citation Analysis]
2 Tian H, Cao J, Li B, Nice EC, Mao H, Zhang Y, Huang C. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Res 2023;11:11. [PMID: 36849442 DOI: 10.1038/s41413-023-00246-z] [Reference Citation Analysis]
3 Wang F, Pu K, Li J. Activating Nanomedicines with Electromagnetic Energy for Deep‐Tissue Induction of Immunogenic Cell Death in Cancer Immunotherapy. Small Methods 2022. [DOI: 10.1002/smtd.202201083] [Reference Citation Analysis]
4 Pandey A, Mishra AK. Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles. BioTech (Basel) 2022;11. [PMID: 36134916 DOI: 10.3390/biotech11030042] [Reference Citation Analysis]